Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial

DOI Full Paper Access

30

Citations

8

References

2012

Year

Richard K. Sterling, Jessica Lim, Lucy Frith, Neil G. Snowise, Loretta Jacques, Brett Haumann

Respiratory Medicine

AsthmaAllergyLong-acting Beta2 AgonistMedicineRandomised TrialClinical TrialsPulmonary PharmacologyPharmacotherapyPharmacologic InterventionPersistent AsthmaPharmacology

References

	Year	Citations

Page 1

Page 1